VRAX

Virax Biolabs (VRAX)

Virax Biolabs Group Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VRAX

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/21	06:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/10/31	21:09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/10/23	21:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/10/23	20:30	PR Newswire (US)	Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/09/30	22:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/09/30	22:13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/09/16	21:30	PR Newswire (US)	Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/09/09	21:00	PR Newswire (US)	Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/29	22:03	PR Newswire (US)	Virax Biolabs to Participate at 7th European Congress of Immunology	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/28	20:30	PR Newswire (US)	Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/24	05:09	PR Newswire (US)	Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/23	21:55	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/23	21:54	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/22	10:30	PR Newswire (US)	Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/21	05:24	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/08/01	20:48	Edgar (US Regulatory)	Form NT 20-F - Notification of inability to timely file Form 20-F	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/06/12	05:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/04/25	21:00	PR Newswire (US)	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/04/16	20:30	PR Newswire (US)	Virax Biolabs to Participate at ESCMID Global 2024	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/03/16	05:30	PR Newswire (US)	Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/01/23	07:28	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/01/23	07:27	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/01/12	21:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	21:34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	21:30	PR Newswire (US)	Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/18	21:37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd